A detailed history of Exane Derivatives transactions in Aurora Cannabis Inc stock. As of the latest transaction made, Exane Derivatives holds 252 shares of ACB stock, worth $1,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares
252
Previous 443 43.12%
Holding current value
$1,501
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$1.23 - $4.14 $234 - $790
-191 Reduced 43.12%
252 $0
Q2 2021

Jul 28, 2021

SELL
$6.86 - $10.23 $397,880 - $593,340
-58,000 Reduced 99.24%
443 $4,000
Q1 2021

Apr 30, 2021

BUY
$8.96 - $18.92 $519,680 - $1.1 Million
58,000 Added 13092.55%
58,443 $544,000
Q2 2020

Jul 10, 2020

BUY
$5.8 - $17.4 $2,569 - $7,708
443 New
443 $5,000

Others Institutions Holding ACB

About AURORA CANNABIS INC


  • Ticker ACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 300,436,992
  • Market Cap $1.79B
  • Description
  • Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried ...
More about ACB
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.